Remdevisir has become a popular word these days, along with Covid-19, Coronavirus, the city of Wuhan, and for a good reason. The headline in all the news, the pricing of remdevisir, has been flooding the internet, and pretty much the TV.
Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19.
FDA allowed FSD Pharma to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
CordenPharma has announced Tuesday its extended agreement with Moderna in its supply of lipids to support the development of Coronavirus Vaccine.
Bioparticle-based delivery system offers potential as a coronavirus therapy LOS ANGELES–(BUSINESS WIRE)–An emerging company developing biotechnology invented at UCLA is…
Abivax said Monday that the German regulatory authority for drugs and medical products, BfArM (Bundesinstitut für Arnzeimittel und Medizinprodukte), has approved its Phase 2b/3 study of ABX464 in COVID-19 patients.
the digital coach from Nori Health is made available for free from their website (use access code UKFREE) with the support of the Primary Care Society for Gastroenterology and its Chair, Dr Kevin Barrett.
Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.
Indica Labs and Octo have announced online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.